Hosted on MSN29d
Trinity Biotech announces breakthrough in CGM technologyJohn Gillard, CEO of Trinity Biotech, emphasized that their patented technology is set to disrupt the CGM market, which is expected to surpass $20 billion by 2029. He highlighted the ergonomic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback